• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Merieux Developpement

edit

Mérieux Développement is the healthcare investment company of Institut Mérieux, a French industrial holding company dedicated to biology, which currently employs more than 10,000 people worldwide. Institut Mérieux has majority ownership of bioMérieux (NYSE Euronext, BIM), Silliker, Transgene (NYSE Euronext, TNG) and ABL Inc. Mérieux Développement intends to invest up to €70 million as minority shareholder from 2010 to 2013 in the field of healthcare on a global basis, working alongside entrepreneurs and innovative companies whose products and services can bring genuine advances to the health of patients and consumers worldwide.

Recent Milestones

edit

• 
  Merieux Developpement invested in NeuroPhage Pharmaceuticals. (5/6/13)
  Posted 5/7/13 at 3:54am via finsmes.com
• 
  Merieux Developpement invested in Biom'Up. (10/26/12)
  Posted 10/26/12 at 2:38am via finsmes.com

Investments

Videos

Sources

1. NeuroPhage Pharmaceuticals Raises $6.4M in Equity Financing (finsmes.com) [edit]
2. Biom’Up Raises €6.8M in Funding (finsmes.com) [edit]